Notes
2013 US dollars
Reference
Farr AM, et al. Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors. Advances in Therapy : 2 Jan 2016. Available from: URL: http://doi.org/10.1007/s12325-015-0277-2
Rights and permissions
About this article
Cite this article
Saxagliptin reduces medical costs compared with sitagliptin. PharmacoEcon Outcomes News 744, 26 (2016). https://doi.org/10.1007/s40274-016-2730-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2730-0